- Tel: 858.663.9055
-
Email: info@nsjbio.com
- Tel: 858.663.9055
- Email: info@nsjbio.com
Related Products
|
AKT1, also known as Protein kinase B alpha (AKT1), is a serine-threonine kinase that serves as a central regulator of the PI3K-AKT signaling pathway, controlling key cellular processes including metabolism, proliferation, survival, and growth. Activation of AKT1 occurs downstream of phosphoinositide 3-kinase signaling and involves phosphorylation-dependent conformational changes that enable kinase activity and downstream substrate targeting. AKT1 is broadly expressed across tissues and plays a fundamental role in maintaining cellular homeostasis under both normal and stress conditions.
AKT1 antibody, also referred to as Protein kinase B alpha antibody and PKB alpha antibody in the literature, recognizes a cytoplasmic and nuclear kinase that is widely used as a marker of PI3K-AKT pathway activity. AKT1 localization can vary depending on activation state, with cytoplasmic, membranous, and nuclear distribution reflecting dynamic signaling events. This flexibility in subcellular localization makes AKT1 a valuable target for studying signal transduction, particularly in tissues where growth factor signaling and metabolic regulation are tightly controlled.
This AKT1 Antibody / PI3K-AKT Signaling and Cancer Marker Antibody (clone AKT1/2552) is uniquely positioned for research focused on signal transduction and oncology. AKT1 is frequently dysregulated in cancer through upstream pathway activation, mutation, or amplification, leading to enhanced cell survival, resistance to apoptosis, and increased proliferative capacity. Elevated AKT1 activity has been implicated in a wide range of tumor types, including breast, prostate, lung, and pancreatic cancers, where it contributes to tumor progression and therapeutic resistance. As a result, AKT1 is a key biomarker for studying oncogenic signaling and evaluating pathway-targeted interventions.
In immunohistochemistry, AKT1 expression is commonly observed in both cytoplasmic and nuclear compartments of epithelial and tumor cells, reflecting its role in coordinating intracellular signaling networks. Western blot analysis typically reveals a band corresponding to the expected size of AKT1, with consistent detection across multiple tissue types due to its broad expression profile. These expression patterns support investigations into tissue-specific signaling dynamics as well as comparative analyses across normal and diseased states.
Microarray validation of clone AKT1/2552 supports its specificity for the AKT1 protein, providing confidence in target recognition across diverse experimental systems. As a mouse monoclonal antibody, clone AKT1/2552 offers reproducible performance for detecting AKT1 expression in research applications. An AKT1 antibody is suitable for detecting AKT1 expression in studies of PI3K-AKT signaling, cancer biology, and cellular regulation where kinase-driven pathways are of central interest.
HER2 signaling activates pathways such as PI3K-AKT and MAPK to regulate cell proliferation and survival; see our HER2 antibody page for upstream receptor detection. This antibody is part of a broader antibody panel offered by NSJ Bioreagents.
Titering of the AKT1 Antibody / PI3K-AKT Signaling and Cancer Marker Antibody may be required for optimal performance.
A portion of amino acids 85-189 from the human protein was used as the immunogen for the AKT1 antibody.
Store the AKT1 antibody at 2-8oC (with azide) or aliquot and store at -20oC or colder (without azide).
AKT1 antibody, Protein kinase B alpha antibody, PKB alpha antibody, RAC-alpha serine threonine kinase antibody, AKT1 cancer signaling antibody
Your bulk quote request has been submitted successfully!
Please contact us if you have any questions.